Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.
about
Young age: an independent risk factor for disease-free survival in women with operable breast cancerCompliance and toxicity of adjuvant CMF in elderly breast cancer patients: a single-center experienceRelationship between the expression of cyclooxygenase 2 and MDR1/P-glycoprotein in invasive breast cancers and their prognostic significanceIdentifying patients at high risk of breast cancer recurrence: strategies to improve patient outcomesAxillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trialContribution of vascular endothelial growth factor to the Nottingham prognostic index in node-negative breast cancerFactors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study.Breast cancer in young women: poor survival despite intensive treatment.Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.Meta-analysis confirms BCL2 is an independent prognostic marker in breast cancer.Population-based assessment of hospitalizations for toxicity from chemotherapy in older women with breast cancerEvaluation of Peripheral Blood Smear for Myelodysplasia in Breast Cancer Patients who Received Adjuvant Antracycline.Breast cancer (metastatic).Molecular detection of minimal residual disease in colorectal and breast cancer.The challenge of sentinel lymph node biopsy.Altering the estrogenic milieu of breast cancer with a focus on the new aromatase inhibitors.High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients.Adjuvant chemotherapy of pT1a and pT1b breast carcinoma: results from the NEMESI studyMicro-metastases in axillary lymph nodes: an increasing classification and treatment dilemma in breast cancer due to the introduction of the sentinel lymph node procedure.A vision for the future?The limited incorporation of economic analyses in clinical practice guidelines.Estrogen receptors as the novel therapeutic biomarker in non-small cell lung cancer.Risk factors and natural history of breast cancer in younger Chinese women.Ethics in sentinel node biopsy in breast cancer: an open question.TP53 status and response to treatment in breast cancersPost-mastectomy radiotherapy for breast cancer patients with t1-t2 and 1-3 positive lymph nodes: a meta-analysis.Biphenotypic acute leukemia following intensive adjuvant chemotherapy for breast cancer: case report and review of the literature.Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes.Reassessing the role of axillary lymph-node dissection in patients with early-stage breast cancerWhat modifies the relation between tumour size and lymph node metastases in T1 breast carcinomas?Does neoadjuvant chemotherapy increase breast conservation in operable breast cancer: an Egyptian experienceDifferent annual recurrence pattern between lumpectomy and mastectomy: implication for breast cancer surveillance after breast-conserving surgery.Molecular profiling of breast cancer: clinical implicationsA Prospective Evaluation of the Association between a Single Nucleotide Polymorphism rs3775291 in Toll-Like Receptor 3 and Breast Cancer RelapseThe impact of expression profiling on prognostic and predictive testing in breast cancer.The adherence paradox: guideline deviations contribute to the increased 5-year survival of breast cancer patientsBreast cancer metastasis and the lymphatic systemGenomic and proteomic approaches for studying human cancer: prospects for true patient-tailored therapy.Comparison of Treatment Outcomes between Breast Conserving Surgery Followed by Radiotherapy and Mastectomy Alone in Patients with T1-2 Stage and 1-3 Axillary Lymph Nodes in the Era of Modern Adjuvant Systemic TreatmentsIdentification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?
P2860
Q24791855-75520697-F860-4756-8441-ED6225353F6DQ24792539-742334C9-C84C-4728-A086-78039B42B012Q24813854-4C261F4B-FCEC-4F45-BCCF-2BD9B6F513C2Q26778675-DB1786D1-9F3C-45B6-916F-55A51371FD15Q28305038-4B2B1EBB-3484-4AF2-B4E6-8EA6D433C688Q28352303-8E89E136-9E52-40EB-9905-8BD31893B1B8Q30313653-A11A8EE7-DA83-44A6-8C37-974D605800D7Q30882889-3A80B324-C15B-4A36-B31C-0B76DC1B9365Q32034551-48A4D3F1-2F94-4794-B272-5BE2CE6AF206Q33338630-3CB937B6-D67B-4DDA-8708-314B3FC2572CQ33345743-B0DA23D4-3A91-42A8-9760-20C6984FA5B3Q33419927-1E66B0E3-6D47-4D07-984C-4FB197B53DD1Q33448016-E72C4CD1-05C9-41A5-8088-85DD368916C6Q33609814-2E2D887B-4669-4B17-9004-8013D36206A8Q33670861-943DCFBE-B8AA-4689-82D3-BC599316FEDDQ33871478-9D5DFDD8-33DD-4A71-8ECD-8A7D76CDBA97Q34123323-651B788F-032D-4DE2-9479-4D2B17E92135Q34251780-1A8560AE-B1A3-449B-A8B7-3CDF5302FE4BQ34478862-176A3040-081E-4F2F-AD93-E579D1ABE82FQ34568113-79D0119B-C729-4265-98A4-0BA5AF17F786Q34585520-08E53342-AE78-4DFF-ADE9-CBAADE281FB8Q34657570-1052F7F7-1BC3-4201-9107-33323B1DBCD7Q34657634-AF5750B2-428D-404D-8789-F0F6CFEAFFF9Q34722692-A9F4326C-C58B-4C05-9F92-409076D3CF08Q35043933-32ED78F4-93EA-4FBB-AA11-0B80E423C5BFQ35061322-CED1C8A8-FA55-4D3B-9BB4-CCC760138C18Q35129681-398C6973-F73A-41FB-99B9-49598A6D743DQ35190944-B8F35627-8F3B-43A9-8EF7-7034558F0903Q35203753-763DC3C3-F2F6-423D-870E-C671F24AE500Q35395211-7519E20E-5B4C-4C89-92EA-23E9E19A1409Q35572879-5B604BD1-253A-424D-94E0-9F754F8B08E3Q35584710-90BE0675-DD83-4BDE-83A7-B1328EF4989CQ35693856-186D3D1E-DCA1-422D-BF6C-C27A2778587AQ35726685-998CCF13-7074-4062-93E1-217998963BB7Q35769768-C2EF956E-838E-4477-A6EB-6B7FAA607256Q35813221-771E2CF3-B448-4EE3-A675-FA724CDF5C9EQ35942984-21829CF8-F7C6-4971-94BC-817C209F4539Q35985492-F0C09B0E-3AB1-4A30-80DA-C4B4AEC70AC9Q36148407-6379DAB5-A9B0-4747-B787-D3AD854E4B5EQ36392789-E2E2B942-A677-46F8-A394-E898A6508BED
P2860
Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
Meeting highlights: Internatio ...... ment of Primary Breast Cancer.
@en
Meeting highlights: Internatio ...... ment of Primary Breast Cancer.
@nl
type
label
Meeting highlights: Internatio ...... ment of Primary Breast Cancer.
@en
Meeting highlights: Internatio ...... ment of Primary Breast Cancer.
@nl
prefLabel
Meeting highlights: Internatio ...... ment of Primary Breast Cancer.
@en
Meeting highlights: Internatio ...... ment of Primary Breast Cancer.
@nl
P2093
P2860
P356
P1476
Meeting highlights: Internatio ...... ment of Primary Breast Cancer.
@en
P2093
A Goldhirsch
R D Gelber
P2860
P304
P356
10.1093/JNCI/90.21.1601
P407
P577
1998-11-01T00:00:00Z